MedPath

Urea

Generic Name
Urea
Brand Names
Cem-urea, Umecta, Utopic
Drug Type
Small Molecule
Chemical Formula
CH4N2O
CAS Number
57-13-6
Unique Ingredient Identifier
8W8T17847W
Background

A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids.

Indication

Urea is used topically for debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, devitalized and ingrown nails.

Associated Conditions
Allergic Skin Reaction, Atopic Dermatitis, Contact Dermatitis, Dermatitis, Dry Eyes, Dry Skin, Dry Skin; Eczema, Eczema, Dyshidrotic, Eye pruritus, Helicobacter Pylori Infection, Insect Bites, Lichen Planus (LP), Neurodermatitis, Nummular Dermatitis, Psoriasis, Seborrheic Dermatitis, Sunburn, Anal eczema, Calluses
Associated Therapies
Moisturizing

Urea for Chronic Hyponatremia

Phase 2
Terminated
Conditions
Hyponatremia
Inappropriate ADH Syndrome
Interventions
First Posted Date
2020-10-19
Last Posted Date
2024-05-20
Lead Sponsor
Helbert Rondon Berrios, MD, MS
Target Recruit Count
2
Registration Number
NCT04588207
Locations
🇺🇸

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Urea Therapy for Hyponatremia in Subarachnoid Hemorrhage

Not Applicable
Recruiting
Conditions
Hyponatremia
Subarachnoid Hemorrhage
SIADH
Interventions
Other: PLACEBO
Drug: Urea
First Posted Date
2020-09-17
Last Posted Date
2023-12-11
Lead Sponsor
University Hospital, Grenoble
Target Recruit Count
52
Registration Number
NCT04552873
Locations
🇫🇷

University Hospital Grenoble, Grenoble, France

Comparison of 12% Ammonium Lactate and 10% Urea Cream in Geriatric With Xerosis Cutis

Phase 3
Completed
Conditions
Xerosis Cutis
Interventions
First Posted Date
2019-10-15
Last Posted Date
2019-10-15
Lead Sponsor
Indonesia University
Target Recruit Count
40
Registration Number
NCT04127513
Locations
🇮🇩

Faculty of Medicine University of Indonesia, Jakarta Pusat, DKI Jakarta, Indonesia

A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema

Phase 4
Completed
Conditions
Hand Eczema
Interventions
First Posted Date
2007-12-19
Last Posted Date
2008-10-13
Lead Sponsor
ACO Hud Nordic AB
Target Recruit Count
53
Registration Number
NCT00576550
Locations
🇳🇴

Medi 3 Innlandet, Hamar, Norway

🇳🇴

Colosseumklinikken, Oslo, Norway

🇳🇴

Dr Funks hudklinikk, Oslo, Norway

Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser

Phase 3
Completed
Conditions
Atopic Eczema
Interventions
First Posted Date
2007-12-19
Last Posted Date
2008-10-13
Lead Sponsor
ACO Hud Nordic AB
Target Recruit Count
55
Registration Number
NCT00576238
Locations
🇸🇪

Nacka hudmottagning, Nacka, Sweden

🇸🇪

Sophiahemmet, Stockholm, Sweden

🇸🇪

Läkarhuset Vällingby, Vällingby, Sweden

and more 2 locations

Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion

Not Applicable
Conditions
Infant, Low Birth Weight
Hyperglycemia
First Posted Date
2000-06-05
Last Posted Date
2005-06-24
Lead Sponsor
National Center for Research Resources (NCRR)
Target Recruit Count
96
Registration Number
NCT00005889
Locations
🇺🇸

Baylor College of Medicine, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath